New dissolvable oral strip provides instant pain relief for burns

New dissolvable oral strip provides instant pain relief for burns
October 16, 2012

Arlington, Va. — A dissolvable oral strip has been developed to immediately relieve pain from burns caused by ingestion of hot foods and liquids, such as coffee, pizza, and soup. This research is being presented at the 2012 American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition, the world's largest pharmaceutical sciences meeting, in Chicago, Ill., on Oct. 14 – 18.

Lead researcher Jason McConville, Ph.D., and colleagues from University of Texas at Austin, designed the strip for controlled delivery of a local anesthetic, benzocaine, and a therapeutic polymer. Benzocaine, commonly used as a topical pain reliever in dental products and throat lozenges, was chosen as for its non-irritating properties.

The strip is applied directly to the burned part of the tongue, cheek or roof of the mouth. It sticks to the affected area and won't interfere with normal day-to-day activities, as it quickly dissolves for instant pain relief and promotes healing.

"We found these strips to be non-toxic, which has huge potential for anyone who burns their mouth while eating and drinking hot foods—and that's just about everyone," said McConville. "The strips look and behave similar to breath freshening strips that you might find at your local drugstore."

Now based at the University of New Mexico, McConville, and his team, will explore creating a stronger oral strip to treat more severe burns lasting longer than 2-3 days. The next step in furthering their research will be to test the strips in humans and experiment with taste-masking.

The 2012 AAPS Annual Meeting and Exposition aims to improve global health through advances in pharmaceutical sciences. The meeting features more than 90 programming sessions, including more than 50 symposia and roundtables.

AAPS is pleased to announce that our smartphone application is available at the 2012 AAPS Annual Meeting and Exposition. This application can assist meeting attendees with anything and everything they need to navigate the conference at their fingertips.

Source: American Association of Pharmaceutical Scientists

Suggested Articles

The new digital Abilify is a breakthrough for Proteus Digital Health and its patient-tracking products, but not so much for Abilify's maker, Otsuka.

Adamis Pharmaceuticals' EpiPen contender Symjepi, which was rejected last year before the EpiPen havoc, won approval from the FDA.

Researchers in the U.K. have developed a technique to better predict results in liver cancer when drug-laden polymer beads are used to deliver medicines.